CHICAGO, Feb. 02, 2023 (GLOBE NEWSWIRE) — According to the new MarketsandMarkets market research report, “HPV Testing and Pap Testing Market Size, growth by test type (HPV test (follow-up HPV test, co-test, primary HPV test), PAP test), end users (laboratories, hospitals, doctor’s offices and clinics), region – global forecast to 2027“, The global HPV testing and Pap testing market has been estimated in terms of revenue at US$4.9 billion in 2022 and is projected to reach US$9.2 billion by 2027 and growing at a compound annual rate from 2022 to 2027 grow by 13.2%.
Browse the detailed table of contents on “HPV Testing and Pap Testing Market“
211 – Tables
35 – figures
180 pages.
Download a clear overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=214207371
Scope of the HPV Testing and Pap Testing Market Report:
| report coverage | details |
| Market value by 2027 | $9.2 billion |
| growth rate | Ready to grow at a CAGR of 13.2% |
| Historical data | 2020-2027 |
| base year | 2021 |
| forecast period | 2022-2027 |
| Forecast Units | Value (Billion USD) |
| report coverage | Sales Forecast, Competitive Landscape, Growth Factors and Trends |
| Covered Segments | By test type, by application, by end user, and by region |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa |
| Profiled key companies/vendors | Abbott Laboratories (USA), Roche Diagnostics (Switzerland), Becton, Dickinson and Company (USA), Hologic, Inc. (USA), Quest Diagnostics (USA), Qiagen NV (Netherlands), Seegene, Inc. (USA), Femasys , Inc. (USA), Arbor Vita Corporation (USA), Mylab Discovery Solutions Pvt. ltd (India), EverlyWell, Inc. (USA), Nurx, Inc. (USA), Dalrada Corporation (USA), NeoDiagnostix (USA), Jiangsu Mole Bioscience Co., Ltd. (China), Sansure Biotech Inc. (China) |
| Important market opportunities | Introduction of HPV primary screening tests |
| Important market drivers | Increasing numbers of HPV cases and an increasing aging of the population |
An increased risk of HPV infection is the main reason for HPV testing …
[ad_2]
Source story
